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DNA and RNA micro- and nanoparticles are increasingly being used for gene and siRNA drug delivery and a variety of
other applications in bionanotechnology. On the nanoscale, these entities represent unique challenges from a physicochemical
characterization perspective. Here, nucleic acid conjugates with protamine and gold nanoparticles (GNP) were characterized
comparatively in the nanorange of concentration by UV/Vis NanoDrop spectroscopy, fluorimetry, and gel electrophoresis. Given
the intense interest in splice-site switching oligomers (SSOs), we utilized a human tumor cell culture system (HeLa pLuc-705), in
which SSO-directed splicing repair upregulates luciferase expression, in order to investigate bioactivity of the bionanoconjugates.
Process parameters important for bioactivity were investigated, and the bimolecular nanoconjugates were confirmed by shifts in
the dynamic laser light scatter (DLLS), UV/Vis spectrum, gel electrophoresis, or sedimentation pattern. The data presented herein
may be useful in the future development of pharmaceutical and biotechnology formulations, processes, and analyses concerning
protein, DNA, or RNA bionanoconjugates.

1. Introduction
Nanoparticles bearing siRNA have been tested recently in
clinical trials [1]. RNA oligonucleotides known as spliceshifting oligomers (SSOs) have the ability to correct errors
that occur in gene splicing at the RNA level, potentially a
novel means of controlling an important molecular pathology underlying cancer [2] and possibly other human diseases
[3]. Although protamine has long been known to bind and
condense DNA into nanoparticles [4] active for gene delivery
[5], condensation of RNA is more controversial [6, 7].

Considering the well-known cell-penetrating and nuclear
localization capabilities of protamine [8], we presume it
could play a critical role for the delivery of SSOs [9].
To investigate the bioactivity and biocompatibility of
the conjugates in this study, we utilize the well-described
HeLa pLuc-705 cell culture system, in which luciferase
is upregulated by delivery of specific SSOs [10–12]. This
luminescence-based assay can be used for quantifying RNA
nanoconjugate delivery. We use this system, along with
high-throughput screening, to explore the process parameters that are important for the RNA nanoconjugate SSO
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bioactivity. To demonstrate the biocompatibility of the
triconjugates, we use the MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) assay to investigate
the metabolic activity of the HeLa pLuc-705 cell line,
after incubation with the conjugates. Recently, we reported
detection of RNA nanoparticles after protamine complexation to RNA by dynamic laser light scatter spectroscopy
(DLLS) [9]. Moreover, gold nanoparticles (GNPs) are taken
up by HeLa cells [13], and surface modification of GNPs
has been shown to aﬀect their interaction at the plasma
membrane and intracellular activity [14]. In this study
we characterize conjugates of GNP, with protamine and
RNA, in comparative analyses using luminometery, UV/Vis
spectroscopy, fluorescence, and gel electrophoresis assays.

2. Experimental
2.1. GNP, Protamine, and Other Reagents. GNPs with a
uniform size of ∼20–30 nm were synthesized using the
standard method of citrate reduction of HAuCl4 salt. Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4 ·3H2 O) was
obtained from Fisher Scientific (Fair Lawn, NJ). Sodium
citrate was obtained from Spectrum Chemical Corp. (New
Brunswick, NJ). To produce the GNPs, an aqueous solution
of HAuCl4 (1 mM, 500 mL) was brought to reflux while
stirring, and 50 mL of 38.8 mM trisodium citrate solution
was rapidly added. After 15 min, the preparation was allowed
to cool to room temperature and subsequently filtered
through a 0.45 µm filter.
Plasmid DNA encoding Hepatitis B DNA vaccine was
obtained as previously described [9]. In some cases, lambda
phage DNA (Sigma-Aldrich) was used in the spectral and
conjugate studies. The protamine stock was purchased from
Sigma-Aldrich as Grade III protamine sulfate salt, derived
from herring. Ribonucleic acid (RNA) diethylaminoethanol
salt Type IX was also purchased from Sigma-Aldrich and
dissolved in RNase-free water just prior to use. A protamine : H2 O standard curve was prepared by dissolving
protamine in water at 2 mg/mL, then performing serial
dilutions to produce 1 mg/mL, 0.5 mg/mL, 0.25 mg/mL,
0.125 mg/mL, and 0.0625 mg/mL solutions. An RNA : H2 O
standard curve was prepared similarly by dissolving RNA
in water at 2 mg/mL, then performing serial dilutions to
produce 1 mg/mL, 0.5 mg/mL, 0.25 mg/mL, 0.125 mg/mL,
and 0.0625 mg/mL solutions.
2.2. High-Throughput Experimental Design to Analyze the
Parameters That Aﬀect Bioactivity. Using the HeLa pLuc705 model, a high-low experimental design was combined
with multiparameter screening with a measurable biological
activity outcome: relative luminescence (RLU) due to the
SSO delivery. The parameters tested included number of
cells, time of transfection, mixation rate, and protamine,
SSO, magnesium, and ethanol concentration, as illustrated
in Figure 2.
2.3. Dynamic Laser Light Scatter Spectroscopy (DLLS). DLLS
was conducted on a Malvern Zetasizer Nano-ZS90. Samples
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were analyzed in 1 mL double-distilled deionized water
in UV-transparent Sarstedt cuvettes. Briefly, 1 mg/mL protamine was added to DNA at 0.1 mg/mL while vortexing
for 5–10 sec and/or to approximately 50 microlitres of GNPs
(3 × 10−8 M). The conjugates were then analyzed directly by
DLLS or UV/Vis spectroscopy.
2.4. Fluorimetric and NanoDrop UV/Vis Spectroscopy. Fluorimetric and NanoDrop UV/Vis spectroscopy was conducted
as described previously [9] for the Hoechst assay, and
the PicoGreen assay was performed in parallel following
manufacturer’s recommendations. RNA stock solutions were
prepared with RNase-free H2 O. Experiments were executed
in triplicate, and indicated by Samples A, B, and C for
each graph. Serial dilution was performed with 250 µL
of solution with 250 µL of RNase free H2 O. Absorbance
spectral scans were performed from 190 to 300 nm on a
Thermo Fisher NanoDrop 2000c. The UV/Vis absorption
spectrum for RNA was also performed in triplicate for
100 ng/µL along with its serial dilution and standard curve
for the absorbance values (ordinate) versus concentration
(abscissa). For the spectral shift experiments, 90 µL of GNP
stock solution was added to 5 µL (10 mg/mL) RNA solution,
5 µL RNase free water, the suspension was vortexed incubated
at room temperature for 15 to 20 mins mixed and read
on the NanoDrop directly. For GNP-Protamine, 90 µL GNP
stock solution and 5 µL (2 mg/mL) stock protamine solution,
5 µL RNase free water was mixed and read as above. For
the GNP-protamine : RNA, 90 µL GNP stock solution and
5 µL (10 mg/mL) RNA solution with 5 µL (2 mg/mL) stock
protamine solution was mixed and read as above.
2.5. Gel Electrophoresis. Gel electrophoresis was accomplished as described previously [9]. Briefly, the gels contained
2% mass/volume agarose in 1X (v/v) TAE buﬀer. Each
RNA sample contained ethidium bromide (Sigma-Aldrich,
St. Louis, MO) at a final concentration of approximately
0.1 mg/mL. Samples contained equal volumes of bromophenol blue loading dye and 5 mg/mL RNA solution. RNA gels
were run at 60 V visualized on a Gel Logic imaging station.
2.6. Sedimentation Coupled to UV/Vis NanoDrop. For the
sedimentation analysis by UV/Vis NanoDrop, all samples were prepared in triplicate, from the following stock
solutions: 200 µL aliquot of the GNP solution, 200 µL of
1.0 mg/mL protamine solution, and 200 µL 5.0 mg/mL RNA
solution.
For the GNP only sample, 20 µL of GNP stock solution
was added to each microcentrifuge tube. The absorbance
from each sample was read, in triplicate, at 525 nm, using
the NanoDrop 2000. The samples were centrifuged for 7
minutes at 15,000 rpm, at 10◦ C. An absorbance reading of
the supernatant was taken immediately, at 525 nm.
For the GNP : protamine sample, 20 µL of GNP stock
solution was added to each microcentrifuge tube, followed
by the addition of 20 µL of protamine stock solution. The
samples were vortexed for 8 seconds, and allowed to incubate
at room temperature for 5 minutes. The absorbance was
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Figure 1: NanoDrop UV/Vis analysis of protamine : RNA and analysis of the sedimentation profiles at 214, 280, 400, and 600 nm.

read; the samples were centrifuged, followed by another
absorbance reading of the supernatant, as stated above.
For the GNP : RNA sample, 20 µL of GNP stock solution
was added to each microcentrifuge tube, followed by the
addition of 20 µL of RNA stock solution. The samples were
vortexed for 8 seconds, and allowed to incubate at room
temperature for 5 minutes. The absorbance was read at
260 nm. After the samples were centrifuged for 7 minutes
at 15,000 rpm, at 10◦ C, an absorbance reading of the supernatant was taken at 260 nm.
For the sedimentation analysis of the triconjugates, 20 µL
of GNP stock solution was added to each microcentrifuge
tube, followed by the addition of 20 µL of protamine stock

solution, and 20 µL of the RNA stock solution. The samples
were vortexed for 8 seconds, and allowed to incubate at
room temperature for 5 minutes. The absorbance was read
at 260 nm; the samples were centrifuged, followed by another
absorbance reading of the supernatant, at 260 nm.
2.7. MTT Assay to Quantify Metabolic Activity after Incubation with Conjugates. Metabolic activity of the HeLa pLuc705 cells was assessed by the reduction of the yellow
tetrazolium salt MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5diphenyltetrazoliumbromide) to purple, insoluble formazan.
All cell culture work was performed under the laminar
flow hood, using sterile technique. The HeLa pLuc-705
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Figure 2: High-throughput screening experimental design analyzing parameters aﬀecting SSO bioactivity in the Hela pLuc-705 system.
RLU: relative luminescence, Lipo-NH2: lipofectamine, Prot: protamine concentration, ETOH: ethanol concentration, Mg++ : magnesium
concentration.
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2

samples were mixed with the pipettes, and the plates were
incubated for 4 hours at 37◦ C. All but 25 µL of the medium
was removed, and 50 µL of DMSO was added to each well
to solubilize the formazan. The solutions were mixed with
the pipette, and allowed to incubate for 10 minutes at
37◦ C. The solutions were mixed again with the pipette, and
the absorbance was read at 540 nm. This experiment was
repeated three times, and the results are graphed in Figure 10.

Figure 3: Hypothetical formation of biomolecular triconjugates of
GNPs, protamine, and nucleic acid (figure not drawn to scale).

3. Results and Discussion
cells, suspended in 1X phenol red-free DMEM/10% FBS/1%
penicillin and streptomycin, were seeded in 96-well plates
in a volume of 100 µL per well. The cells were incubated at
37◦ C overnight, to allow them to attach. The DMEM was
removed, and the cells were carefully washed with sterile 1X
PBS. The GNPs and the conjugates, prepared as previously
described, were centrifuged for 7 minutes at 15,000 rpm. The
supernatant was removed, and the pellets were resuspended
in serum-free, phenol red-free DMEM. From these solutions,
100 µL was added to each well, with 24 wells containing the
GNPs and medium only, 24 wells containing the conjugates
and medium, and 24 wells containing only the serumfree, phenol red-free medium. The plates were incubated
overnight at 37◦ C. After incubation, the medium was
removed and the cells were washed with sterile 1X PBS to
remove any GNPs or conjugates, to avoid any interference
with the absorbance readings. To each well, 100 µL of fresh
serum-free, phenol red-free medium was added, along with
10 µL of a 12 mM MTT stock solution, prepared by adding
1 mL of sterile 1X PBS to 5 mg MTT (Invitrogen). The

3.1. Analysis and Sedimentation of Protamine : RNA. Direct
NanoDrop measurement of protamine : RNA and microfuge
sedimentation are shown in Figure 1. Macromolecule
(tRNAphe ), rapidly mixed on a dual pump flow head with
protamine, was sedimented at 13 k, and the supernatant
and pellet or supernatant fractions tested on a NanoDrop
UV/Vis instrument at 214, 260, 400, or 600 nm for peptide,
RNA, or particle light scatter properties, respectively. The
data demonstrate quantitative transferal of the protamine
and RNA from the supernatant to the pellet. Light scatter of
the particles formed is measured at 400 or 600 nm.
3.2. Measuring SSO Bioactivity in the HeLa pLuc-705 Model.
We investigated the parameters that are important for SSO
bioactivity in a high-low two-level experimental design. The
experimental design and the data are shown in Figure 2.
By looking at the relative luminescence (RLU), we conclude
that the protamine concentration demonstrated the greatest
positive outcome on splice-shifting activity whereas magnesium and ethanol concentration had a negative eﬀect [15].
As shown in Figure 2, formulation-process variables were
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Figure 4: NanoDrop UV/Vis spectra (GNP, protamine, and RNA). Linear range in inset.

shown to aﬀect the cells’ luminescence by as much as 105 –
106 over background.
3.3. Au-Protamine : RNA Conjugates. GNPs are taken up by
HeLa cells [13]. SSO delivery requires membrane penetration

and nuclear localization, both of which are known capabilities of protamine [8]. Therefore, our next step was to create
conjugates of GNP with protamine as illustrated in Figure 3.
As diagrammed in Step 1, positively charged protamine
molecules bind to the negatively charged gold nanoparticles
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3.5. Fluorescence Analysis of DNA in the Nanorange. Doublestranded DNA (dsDNA) triconjugates with GNP and protamine can also be constructed. Concentration of dsDNA is
obtained in the nanogram per microliter range by PicoGreen
or Hoechst assays. Standard curves for dsDNA analysis,
where fluorescence is a function of the DNA concentration,
are shown in Figure 5.

created by the citrate surface. In Step 2, negatively charged
RNA molecules bind to the positively charged protamine
molecules bound to a gold nanoparticle, completing the
protamine/RNA/gold nanoparticle triconjugate.

3.6. Analysis of the Conjugates by Sedimentation. GNP, GNPprotamine, or GNP-protamine : RNA samples were analyzed
on the UV/Vis NanoDrop before or after sedimentation on a
microcentrifuge. The GNP in the supernatant was monitored
at 525 nm and the RNA at 260 nm as described previously.
These data are shown in Figure 6.
As can be seen in the figure, the greatest loss from
the supernatant, based on the absorbance of the starting
material, occurred for GNP-protamine : RNA triconjugate,
thereby indicating the interaction of all three components.

3.4. Nano-Drop UV/Vis Analysis of the Nanoconjugate Components. The individual components of the triconjugates
(e.g., GNP, protamine, or RNA) can be monitored by

3.7. Analysis of the Conjugates by Gel Shift. In a parallel
experiment to that shown above in Figure 6, the GNP, GNPRNA, or GNP-protamine : RNA were analyzed by agarose
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3.8. Surface Charge and Size of the Conjugates. Zeta potential
of the GNPs in the presence or absence of protamine and/or
nucleic acid (DNA in this case) is shown in Figure 8(a).
Potential of GNP alone was slightly less than zero. On
the other hand, when protamine was added to either the
GNPs or DNA, the zeta potential value increased to 12.5 mV
and 13.4 mV, respectively, due to the positive charges on
protamine. When all three were combined, the zeta potential
value decreased to 1.20 mV, indicating a strong interaction.
Figure 8(b) shows the expected eﬀect of conjugation
on the particle’s size. For the sample containing only the
GNPs, the particle size is estimated to be approximately
38 nm. After complexing the GNP with protamine, as previously described, the particle size increases to approximately
200 nm. When the DNA is added, the sizes increases accordingly, to approximately 420 nm. This is further evidence that
the conjugates are formed with all three components.
3.9. Spectral Shift upon Conjugate Formation. The GNP
spectrum, shown in Figure 9, demonstrates the absorbance
peak at approximately 520–530 nm, characteristic of particles
in the low nanometer size range used here. The spectrum of
the DNA displays the typical nucleic peak at 260 nm, which
exhibits a greatly increased absorbance after interaction with
protamine or protamine : gold. The mixture of DNA and
protamine produced spectra that indicated strong interactions between the two molecules. The protamine : nucleic
acid interaction is incompletely understood, and although
the zeta potential data above suggest that the interaction is
electrostatic in nature, the data also reveal an enhancement
of absorbance for the DNA peak at 260 nm, thus implicating

0.6

Absorbance

gel electrophoresis. These data are shown in Figure 7. A
slight shift was observed upon interaction of RNA with GNP,
and a more obvious shift occurred after the introduction of
protamine, again suggesting the presence of the triconjugate
species. Increased staining intensity in the well was observed
previously for protamine : RNA nanoparticles [9].
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Figure 9: Evidence for bionanoconjugates made between GNPs,
protamine, and DNA by UV/Vis.

some structural rearrangement. RNA : protamine and GNPprotamine : RNA were amplified and shifted further (data
not shown).
3.10. Biocompatibility of Triconjugates. As previously reported, gold nanoparticles are taken up by HeLa cells [13].
The absorbance readings shown below, in Figure 10, confirm
that the HeLa pLuc-705 cells retained their metabolic activity
after the 24-hour incubation time with gold nanoparticles
only, and with conjugates of gold nanoparticles, protamine,
and RNA. This confirms that the conjugates are not cytotoxic, and this is a safe system for SSO delivery.

4. Conclusions
The high-low screening design experiment demonstrated
that protamine, ethanol, and magnesium yielded the greatest
influence on SSO bioactivity. The data, therefore, suggest
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that creating conjugates in which protamine could aﬃx RNA
onto the GNP might be warranted. The data contraindicates
condensing and/or precipitating protamine : RNA nanoparticles as a result of varying the ionicity and hydrophobicity [6, 15]. Modeling of protamine, based on dark field
microscopy [16] and earlier studies [17, 18], suggests that
protamine condenses DNA into nanoparticles, which here we
hypothesize (Figure 3) can be extended to entrap RNA onto
the protamine-GNP conjugates.
To understand the triconjugate of RNA, GNPs, and
protamine by UV/Vis spectroscopy, it is first necessary to
determine the spectrum of each component individually.
Changes in the wavelength or peak amplitude after addition
of a second and third component suggests their interaction
whereas unchanged peaks indicate their dispersion. In
erefFigurefig4, the individual peaks for nucleic acid, GNPs,
and protamine are illustrated, which are compared subsequently to solutions of these components in combination,
seen in Figure 9. Again, shifts in the amplitude or absorbance
maximum in the RNA or gold UV/Vis spectra suggest triconjugate interaction between the three species: protamine,
RNA, and GNP.
NanoDrop UV/Vis has nanorange sensitivity like its fluorescence counterparts, the PicoGreen and Hoechst assays,
yet is not dependent on a double-stranded nucleic acid
fordye binding. Although UV/Vis data suggests interaction
between the triconjugates, at present it is uncertain that
these fluorescent dyes can confirm this putative interaction;
however, we did note a slight gel shift after staining with the
fluorescent dye ethidium and consider this observation to be
consistent with interactions between GNP, protamine, and
RNA.
The NanoDrop instrument can rapidly quantify nucleic
acids, protamine, or gold conjugates in UV or visible mode in

the nanomolar or nanogram per microliter range, although
its utility in evaluating breakdown products or biomaterial
and nanomaterial compatibility with proteins and nucleic
acids remains in question. For on-particle analysis, however,
DLLS and NanoDrop UV/Vis observations are critical for
optimizing preparation and delivery.
There is substantial interest in the formulation and
delivery of therapeutic nucleic acids as nanoparticles for
delivery in humans [1]. Here, methods amenable for the
analysis of macromolecular RNA and DNA, and those
present as nanoparticles, have been compared. DLLS, fluorimetric, UV/Vis spectroscopic, and electrophoretic methods
are all capable of nanorange detection. Accordingly, these
assays are likely to have mainstay applications in the clinical
progression of delivering nucleic acids into patients in the
form of nanoparticles.
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